Type: (null)
Journal: Technology in Cancer Research and Treatment
Year: 2014
Pages: 13, 77-86
MicroRNA-34a Targets Bcl-2 and Sensitizes Human Hepatocellular Carcinoma Cells to Sorafenib Treatment
Distribution of the number of citations over years.